Huntsman Cancer Institute

Articles

Novel Prostate Cancer Treatment Increases Overall Survival Rates for Late-Stage Prostate Cancer Patients

October 31st 2024

Results of the TALAPRO-2 trial showed that a novel prostate cancer therapy has a higher overall survival rate compared to the standard of care drug alone.

Researchers Develop Mechanism that Predicts Severity of Aggressive Form of Breast Cancer

September 13th 2024

Scientists at Huntsman Cancer Institute at the University of Utah, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer.

Landmark Study Shows Elevated Cancer Risk For Women With Endometriosis

July 23rd 2024

Women with severe endometriosis are 10 times more likely to get ovarian cancer, compared to women who do not have the disease.

Researchers Honored for Outstanding Contributions to Cancer Care

June 21st 2024

Three Huntsman Cancer Institute researchers have recently been recognized for their work as outstanding faculty members at the University of Utah.

The Surprising Connection Between Male Infertility and Family Cancer Risk

May 6th 2024

In a recent study, researchers at Huntsman Cancer Institute found a trend in families with male infertility: an increased risk of certain cancers.

Utah Governor’s Medal Given to Neli Ulrich, PhD, MS, for Outstanding Research and Leadership

May 1st 2024

Neli Ulrich, PhD, MS, of Huntsman Cancer Institute, has been awarded the 2024 Governor’s Medal for Science and Technology.

Gita Suneja Named Senior Director of Programs to Enhance Diversity

April 5th 2024

Gita Suneja, MD, MS, has been named the senior director of Programs to Enhance Diversity at Huntsman Cancer Institute.

Utah Legislature Allocates $75 Million to Vineyard Cancer Research Center

March 28th 2024

Huntsman Cancer Institute at the University of Utah received $75 million from the Utah Legislature toward a cancer research and academic building.

New Digital Tool Aims to Improve Treatment Plans for Pediatric Cancer Patients

February 21st 2024

Jonathan Constance, PhD, and his team have created a digital pharmacology platform for assessing drug dynamics directly among children with cancer.

Single-port Robotic Surgery Is Making Its Debut In The Mountain West

February 7th 2024

Huntsman Cancer Institute introduces the first and only single-port robot in the Mountain West for head and neck surgical oncology patients.

New Impactful Leadership Roles at Huntsman Cancer Institute

January 23rd 2024

Huntsman Cancer Institute has appointed new roles for Theresa Werner, MD, and Neeraj Agarwal, MD, FASCO.

Male Breast Cancer Diagnosis Fuels Groundbreaking Treatment Tool

January 14th 2024

Doctors diagnosed Christopher Gregg, PhD, with stage IV metastatic breast cancer in 2018. Then, he started thinking of ways to improve his treatment.

Alana Welm, PhD, Receives Award For Breast Cancer Research

January 10th 2024

Alana Welm, PhD, received the 2023 American Association for Cancer Research Outstanding Investigator Award for Breast Cancer Research.

Huntsman Cancer Institute Researchers Find Link Between Folic Acid and Blood Cell Production

December 27th 2023

Researchers at Huntsman Cancer Institute at the University of Utah discovered that the level of blood and immune cells in mouse model offspring would fluctuate based on the amount of folic acid consumed by their mothers during pregnancy.

Digital Tools Quadruple Rate of Lifesaving Lung Cancer Screening

December 23rd 2023

Researchers at University of Utah Health have designed new digital tools that use relevant information from patient health records to prompt doctors to consider lung cancer screening for high-risk patients and provide personalized guidance on screening.

A Year of Excellence: 2023 WebMD Elite Choice Award

December 22nd 2023

WebMD awarded Huntsman Cancer Institute at the University of Utah its highest honor, the 2023 WebMD Elite Choice Award.

New Clinical Trials Test Innovative Ways To Preserve Muscle Mass During Metastatic Prostate Cancer

October 25th 2023

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

Shaping the Future of Cancer Care Through Student Training Health Collaborative

October 20th 2023

Huntsman Cancer Institute at the University of Utah and Utah Valley University proudly announce a groundbreaking partnership called the “Huntsman Cancer Institute–Utah Valley University Health Collaborative.”

Estrogen Receptor Mutation Study Suggests Potential Treatments For Endometrial Cancers

August 28th 2023

Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.

Huntsman Cancer Institute Research Highlights For July 2023

August 10th 2023

This month, researchers reduce the risk of infections after pancreatic surgery and discover the best cost-effective treatment combination for prostate cancer patients.